DK0871656T3 - Dolastatinderivater, deres fremstilling og anvendelse - Google Patents

Dolastatinderivater, deres fremstilling og anvendelse

Info

Publication number
DK0871656T3
DK0871656T3 DK96918661T DK96918661T DK0871656T3 DK 0871656 T3 DK0871656 T3 DK 0871656T3 DK 96918661 T DK96918661 T DK 96918661T DK 96918661 T DK96918661 T DK 96918661T DK 0871656 T3 DK0871656 T3 DK 0871656T3
Authority
DK
Denmark
Prior art keywords
preparation
dolastatin derivatives
dolastatin
derivatives
Prior art date
Application number
DK96918661T
Other languages
Danish (da)
English (en)
Inventor
Andreas Haupt
Franz Emling
Cynthia A Romerdahl
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Application granted granted Critical
Publication of DK0871656T3 publication Critical patent/DK0871656T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK96918661T 1995-06-07 1996-06-03 Dolastatinderivater, deres fremstilling og anvendelse DK0871656T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/472,453 US5831002A (en) 1992-05-20 1995-06-07 Antitumor peptides
PCT/EP1996/002393 WO1996040752A1 (en) 1995-06-07 1996-06-03 Novel dolastatin derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
DK0871656T3 true DK0871656T3 (da) 2003-01-27

Family

ID=23875567

Family Applications (2)

Application Number Title Priority Date Filing Date
DK96918660T DK0832104T3 (da) 1995-06-07 1996-06-03 Dolastatinderivater, deres fremstilling og anvendelse
DK96918661T DK0871656T3 (da) 1995-06-07 1996-06-03 Dolastatinderivater, deres fremstilling og anvendelse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK96918660T DK0832104T3 (da) 1995-06-07 1996-06-03 Dolastatinderivater, deres fremstilling og anvendelse

Country Status (33)

Country Link
US (1) US5831002A (ko)
EP (2) EP0871656B1 (ko)
JP (2) JP3957751B2 (ko)
KR (2) KR100437986B1 (ko)
CN (2) CN1182154C (ko)
AR (2) AR003136A1 (ko)
AT (2) ATE223431T1 (ko)
AU (2) AU725164B2 (ko)
BG (2) BG102125A (ko)
BR (2) BR9609424A (ko)
CA (2) CA2219819C (ko)
CO (2) CO4700526A1 (ko)
CZ (2) CZ293682B6 (ko)
DE (2) DE69623472T2 (ko)
DK (2) DK0832104T3 (ko)
ES (2) ES2186783T3 (ko)
HR (2) HRP960277A2 (ko)
HU (2) HU228073B1 (ko)
IL (2) IL122216A (ko)
MX (2) MX9709147A (ko)
MY (2) MY119042A (ko)
NO (2) NO318384B1 (ko)
NZ (2) NZ310444A (ko)
PL (2) PL185762B1 (ko)
PT (2) PT832104E (ko)
RO (2) RO119783B1 (ko)
SI (2) SI0871656T1 (ko)
SK (1) SK282466B6 (ko)
TR (2) TR199701544T1 (ko)
TW (2) TW508357B (ko)
UA (2) UA46776C2 (ko)
WO (2) WO1996040752A1 (ko)
ZA (2) ZA964710B (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
US20010009901A1 (en) * 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6103698A (en) * 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6015790A (en) * 1997-10-06 2000-01-18 Basf Aktiengesellschaft Methods and compositions for treating rheumatoid arthritis
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
CA2360740A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
CN100350036C (zh) 2001-04-27 2007-11-21 宝洁公司 用于控制生物膜的装置和方法
AU2002359792A1 (en) * 2001-12-18 2003-06-30 Proteologics, Inc. Methods and compositions for the inhibition of viral release
EP1531846A4 (en) * 2002-02-27 2006-04-19 Us Gov Health & Human Serv CONJUGATES OF LIGAND, LINK AND CYTOTOXIC AGENS, AND RELATED COMPOSITIONS AND USE PROCESSES
EP1781310B1 (en) 2004-08-02 2015-10-14 Ramot at Tel Aviv University Ltd. Articles of peptide nanostructures and method of forming the same
EP1883627B1 (en) 2005-05-18 2018-04-18 Pharmascience Inc. Bir domain binding compounds
WO2007024574A2 (en) * 2005-08-19 2007-03-01 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Topical formulations of histone deacetylase inhibitors and methods of using the same
EP1973928A2 (en) * 2005-10-11 2008-10-01 Ramot at Tel-Aviv University Ltd. Self-assembled fmoc-ff hydrogels
AU2007250443B2 (en) 2006-05-16 2013-06-13 Pharmascience Inc. IAP BIR domain binding compounds
WO2008014252A2 (en) * 2006-07-24 2008-01-31 Tetralogic Pharmaceuticals Corporation Iap inhibitors
WO2008127560A1 (en) 2007-04-12 2008-10-23 Scinopharm Taiwan Ltd. Process for making galantamine
UY32099A (es) 2008-09-11 2010-04-30 Enanta Pharm Inc Inhibidores macrocíclicos de serina proteasas de hepatitis c
US8283372B2 (en) 2009-07-02 2012-10-09 Tetralogic Pharmaceuticals Corp. 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
ES2625637T3 (es) 2010-02-12 2017-07-20 Pharmascience Inc. Compuestos de unión al dominio BIR IAP
KR20140003521A (ko) 2010-12-30 2014-01-09 이난타 파마슈티칼스, 인코포레이티드 페난트리딘 매크로사이클릭 ｃ형 간염 세린 프로테아제 억제제
CN103534256B (zh) 2010-12-30 2016-08-10 益安药业 大环丙型肝炎丝氨酸蛋白酶抑制剂
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
JP6581774B2 (ja) * 2011-05-27 2019-09-25 アンブルックス, インコーポレイテッドAmbrx, Inc. 非天然アミノ酸結合ドラスタチン誘導体を含有する化合物またはその化合物の溶媒和物、およびドラスタチンアナログを誘導体化するための方法
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
AU2022338463A1 (en) 2021-09-03 2024-03-21 Toray Industries, Inc. Pharmaceutical composition for cancer treatment and/or prevention

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
DK0934950T3 (da) * 1991-08-09 2002-07-29 Teikoku Hormone Mfg Co Ltd Tetrapeptidderivat
AU669710B2 (en) * 1992-05-20 1996-06-20 Abbott Gmbh & Co. Kg Derivatives of dolastatin
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters

Also Published As

Publication number Publication date
NO975711D0 (no) 1997-12-05
NO975710D0 (no) 1997-12-05
IL122216A0 (en) 1998-04-05
EP0871656B1 (en) 2002-09-25
MX9709147A (es) 1998-03-31
SK165397A3 (en) 1998-10-07
BR9609424A (pt) 2000-03-28
RO119783B1 (ro) 2005-03-30
IL122215A (en) 2001-08-26
TR199701545T1 (xx) 1998-04-21
JPH11504653A (ja) 1999-04-27
TR199701544T1 (xx) 1998-03-21
CZ376597A3 (cs) 1998-06-17
KR19990022582A (ko) 1999-03-25
DE69623472T2 (de) 2003-08-21
SK282466B6 (sk) 2002-02-05
SI0832104T1 (en) 2003-08-31
CN1182154C (zh) 2004-12-29
BR9609423A (pt) 1999-06-29
DE69623992D1 (de) 2002-10-31
PT871656E (pt) 2002-12-31
PL185762B1 (pl) 2003-07-31
MX9709146A (es) 1998-03-31
BG102125A (en) 1998-09-30
US5831002A (en) 1998-11-03
JP4221062B2 (ja) 2009-02-12
NO975711L (no) 1998-01-30
AU6124196A (en) 1996-12-30
DE69623472D1 (de) 2002-10-10
CA2219819A1 (en) 1996-12-19
MY124487A (en) 2006-06-30
WO1996040751A1 (en) 1996-12-19
AU725164B2 (en) 2000-10-05
CA2219818C (en) 2008-05-20
UA46776C2 (uk) 2002-06-17
EP0832104B1 (en) 2002-09-04
AU6124296A (en) 1996-12-30
HRP960257A2 (en) 1998-02-28
BG102152A (en) 1998-09-30
ZA964710B (en) 1997-12-08
AR003427A1 (es) 1998-08-05
NZ310444A (en) 1999-11-29
KR19990022583A (ko) 1999-03-25
ATE224910T1 (de) 2002-10-15
PL323723A1 (en) 1998-04-14
PL185763B1 (pl) 2003-07-31
SI0871656T1 (en) 2003-08-31
CN1182153C (zh) 2004-12-29
EP0871656A1 (en) 1998-10-21
HUP9801910A2 (hu) 1999-01-28
CN1187198A (zh) 1998-07-08
DK0832104T3 (da) 2003-01-06
HU228071B1 (hu) 2012-09-28
TW424096B (en) 2001-03-01
JP3957751B2 (ja) 2007-08-15
NO318384B1 (no) 2005-03-14
TW508357B (en) 2002-11-01
RO118953B1 (ro) 2004-01-30
CA2219819C (en) 2008-05-20
MY119042A (en) 2005-03-31
AR003136A1 (es) 1998-07-08
CZ293683B6 (cs) 2004-07-14
EP0832104A1 (en) 1998-04-01
PT832104E (pt) 2002-12-31
AU725170B2 (en) 2000-10-05
HRP960277A2 (en) 1997-10-31
JPH11504652A (ja) 1999-04-27
CO4700527A1 (es) 1998-12-29
NO975710L (no) 1998-02-02
WO1996040752A1 (en) 1996-12-19
HU228073B1 (hu) 2012-09-28
IL122215A0 (en) 1998-04-05
ES2186783T3 (es) 2003-05-16
HUP9801910A3 (en) 1999-06-28
ATE223431T1 (de) 2002-09-15
KR100437986B1 (ko) 2004-09-18
ES2188759T3 (es) 2003-07-01
CO4700526A1 (es) 1998-12-29
NZ310443A (en) 1999-10-28
UA46775C2 (uk) 2002-06-17
PL323726A1 (en) 1998-04-14
NO317670B1 (no) 2004-11-29
DE69623992T2 (de) 2003-05-22
CZ376397A3 (cs) 1998-06-17
HUP9801817A3 (en) 1999-06-28
ZA964711B (en) 1997-12-08
CZ293682B6 (cs) 2004-07-14
CN1187199A (zh) 1998-07-08
HUP9801817A2 (hu) 1998-11-30
CA2219818A1 (en) 1996-12-19
IL122216A (en) 2002-02-10
KR100437985B1 (ko) 2004-09-18

Similar Documents

Publication Publication Date Title
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO954369D0 (no) Oksazolidindionderivater, deres fremstilling og anvendelse
NO961160L (no) Cykliske forbindelser, deres fremstilling og anvendelse
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO961721D0 (no) 2-oksetanon-limingsmidler, deres fremstilling og bruk
NO981282D0 (no) Calcitriolderivater og deres anvendelser
NO975020D0 (no) Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi
NO953673D0 (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
NO962477D0 (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO951418D0 (no) Peptidderivater, deres fremstilling og anvendelse som terapeutika
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO954763D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
NO973230D0 (no) Nye peptider, deres fremstilling og anvendelse
NO980471D0 (no) Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO972821D0 (no) 1-C-perfluoralkylglycosider, deres fremstilling og anvendelse
NO981002D0 (no) Karboksylsyrederivater, deres fremstilling og anvendelse
NO982549D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav